Rofecoxib as adjunctive therapy for haemophilic arthropathy

Haemophilia

Volumn 11, Issue 3, 2005, Pages 240-244

  Rattray, B ^a   Nugent, D J ^a   Young, Guy ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Factor; Haemophilia; Inflammation; Paediatric; Therapy

Indexed keywords

BLOOD CLOTTING FACTOR 8; CYCLOOXYGENASE 2 INHIBITOR; ROFECOXIB;

ADOLESCENT; ADULT; ARTHRALGIA; ARTHROPATHY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HEMARTHROSIS; HEMATURIA; HEMOPHILIA; HUMAN; MEDICAL RECORD; ORAL BLEEDING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYNOVITIS;

ACUTE DISEASE; ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYCLOOXYGENASE INHIBITORS; HEMARTHROSIS; HEMOPHILIA A; HEMOPHILIA B; HUMANS; LACTONES; PAIN; SULFONES; SYNOVITIS; TREATMENT OUTCOME;

EID: 19444363676     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2005.01087.x     Document Type: Article

References (19)

1. Carcao MD, Aledort L. Prophylactic factor replacement in hemophilia. Blood Rev 2004; 18: 101-13.
2. Dunn AL, Busch MT, Wyly JB, Abshire TC. Radionuclide synovectomy for hemophiliac arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol. Thromb Haemost 2002; 87: 383-93.
3. Walsh DA, Pearson CI. Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res Ther 2001; 3: 147-53.
4. Nilsson IM, Berntrop E, Lofqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
5. Lofqvist T, Nilsson IM, Berntorp E, Petterson H. Haemophilia prophylaxis in young patients - a long term follow up. J Intern Med 1997; 241: 395-400.
6. Valentino LA. Secondary prophylaxis therapy: what are the benefits, limitations, and unknowns? Haemophilia 2004; 10: 147-57.
7. Dunn AL, Busch MT, Wyly JB, Abshire TC. Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol. Thromb Haemost 2002; 87: 383-93.
8. Journeycake JM, Miller KL, Anderson AM, Buchanan GR, Finnegan M. Arthroscopic synovectomy in children and adolescents with hemophilia. J Pediatr Hematol Oncol 2003; 25: 726-31.
9. Fitzgerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001; 345: 433-42.
10. Narayanan BA, Narayanan NK, Pittman B, Reddy BS. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Clin Cancer Res 2004; 10: 7727-37.
11. Woods JM, Mogollon A, Amin MA, Martinez RJ, Koch AE. The role of COX-2 in angiogenesis and rheumatoid arthritis. Exp Mol Pathol 2003; 74: 282-90.
12. Bragodottir G, Onundarson PT. Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy. Haemophilia 2002; 8: 828-33.
13. Bombardier C, Laine L, Reicin A et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343: 1520-8.
14. Ruschitzka FT. The APPROVe Study: what we should learn from the VIOXX withdrawal. Curr Hypertens Rep 2005; 7: 41-3.
15. Sramek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003; 362: 351-4.
16. Rosendaal FR, Varekamp I, Smit C et al. Mortality and causes of death in Dutch haemophiliacs, 1973-86. Br J Haematol 1989; 71: 71-6.
17. Graham DJ. Risk of acute cardiac events among patients treated with cyclooxygenase-2 selective and non-selective nonsteroidal antiinflammatory drugs. Pharmacoepidemiol Drug Saf 2004; 13(suppl 1): S287.
18. White WB, Faich G, Borer JS, Makuch RW. Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. Am J Cardiol 2003; 92: 411-8.
19. Stempak D, Gammon J, Klein J, Koren G, Baruchel S. Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther 2002; 72: 490-7.